By Iain Gilbert
Date: Thursday 02 Oct 2025
(Sharecast News) - Optibiotix Health revealed on Thursday that finance director David Blain had acquired 84,053 ordinary shares in the AIM-listed life sciences business.
| Holding(s) in Company | 13-Oct-2025 | 15:31 | RNS |
| Director/PDMR Shareholding | 02-Oct-2025 | 07:00 | RNS |
| Director/PDMR Shareholding | 24-Sep-2025 | 12:28 | RNS |
| Half-year Report | 16-Sep-2025 | 07:00 | RNS |
| Admission to Trading on the OTCQB Venture Market | 21-Aug-2025 | 07:00 | RNS |
| £5.7m float for weight-fighting OptiBiotix after... | 04-Aug-2014 | Express & Star |
No recent information was found.
No recent information was found.
| Currency | UK Pounds |
| Share Price | 7.75p |
| Change Today | -0.25p |
| % Change | -3.13 % |
| 52 Week High | 22.60 |
| 52 Week Low | 7.75 |
| Volume | 251,532 |
| Shares Issued | 103.30m |
| Market Cap | £8.01m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:49 | 13,946 @ 7.77p |
| 14:53 | 61,271 @ 8.15p |
| 14:02 | 30,000 @ 8.16p |
| 13:06 | 1,176 @ 8.16p |
| 13:03 | 1,176 @ 8.50p |
| CEO | Stephen O'Hara |
| Finance Director | David Blain |
You are here: research